4'-methoxy-N,N-dimethyl-3'-(N-(3-((2-(3-methylbenzamido)ethyl)amino)phenyl)sulfamoyl)-(1,1'-biphenyl)-3-carboxamide,
Orexin 2 Receptor Agonist,
1796565-52-0,
CHEMBL3623075,
N-[2-[3-[[5-[3-(dimethylcarbamoyl)phenyl]-2-methoxyphenyl]sulfonylamino]anilino]ethyl]-3-methylbenzamide,
Orexin2ReceptorAgonist,
Nag26,
OX2R,
Nag 26,
GTPL9305,
SCHEMBL18138813,
KS-00001DER,
BCP17168,
EX-A1216,
MDK-5220,
BDBM50121214,
AKOS030526668,
ZINC473136423,
CS-5456,
SB19183,
MDK-5220(Orexin-2 receptor agonist),
compound 26 [PMID: 26267383],
AK547566,
HY-19320,
[1,1'-Biphenyl]-3-carboxamide, 4'-methoxy-N,N-dimethyl-3'-[[[3-[[2-[(3-methylbenzoyl)amino]ethyl]amino]phenyl]amino]sulfonyl]-,
3-(4-methoxy-3-{[3-({2-[(3-methylphenyl)formamido]ethyl}amino)phenyl]sulfamoyl}phenyl)-N,N-dimethylbenzamide,
4'-methoxy-N,N-dimethyl-3'-(N-(3-((2-(3-methylbenzamido)ethyl)amino)phenyl)sulfamoyl)-[1,1'-biphenyl]-3-carboxamide,
N-(2-(3-(4-Methoxy-3'-dimethylcarbamoyl-3-biphenylylsulfonylamino)anilino)ethyl)-3-methylbenzamide,
A15982,